• About Robert Gadimian

    A pharmaceutical regulatory affairs professional with more than 25 years of experience, Robert Gadimian works with clients in the drug development sector to fulfill the necessary requirements for approval by the FDA and other international health authorities. Robert Gadimian does this through Perceptive Regulatory Consulting, his own consulting agency based in Burbank, California.

    Mr. Gadimian concurrently serves as president of Rophe Pharma, where he has a patent pending for a novel product targeting hair and eyebrow growth. He has already secured patents for several unique compounds that treat such conditions as arthritis, diabetic foot ulcers, and cystic fibrosis. Through Rophe Pharma, Mr. Gadimian raises the venture capital necessary to fund research into these products, and assists with study design and overall strategy.

    To inform his work at these two companies, Mr. Gadimian relies on his extensive hands-on experience and formal education in the pharmaceutical sector. Over the course of his career, he oversaw regulatory affairs for such major pharmaceutical companies as Cougar Biotechnology, Abraxis BioScience, and Abbott Laboratories. He received a master’s in pharmacy from Uppsala University in Sweden, studied food and drug law at Temple University, and earned Regulatory Affairs Certification through the Regulatory Affairs Professional Society.

  • Education 

    Uppsala University

    MS (1992 - 1996)

    Pharmacy

  • Professional Experience

    Perceptive-Regulatory Consulting

    Oct 2016 - Present

    President

  • Contact

    Pinterest

    Website

    Wordpress

  • The Blog

    A recipient of an MS in pharmacy from Uppsala University Pharmacy School in Sweden, Robert Gadimian has more than 20 years of experience in the pharmaceutical industry. Presently leading as the president of Rophe Pharma, Robert Gadimian and his C corporation have been working on the creation of...
    As head of Perceptive Regulatory Consulting, Robert Gadimian provides actionable pathways toward achieving FDA approval for innovative drugs. In his position as Rophe Pharma head, Robert Gadimian is also engaged in drug formulation efforts spanning conditions such as diabetic foot ulcers and male...
    All Posts
    ×